Navigation Links
BioForm Reports Financial Results for the Fourth Quarter and Full Fiscal Year Ended June 30, 2008
Date:9/4/2008

in gross profit margin for the quarter ended June 30, 2008 was primarily due to a variation of production volume and overhead expense incurred, and lower royalty license expense.

Operating expenses were $34.7 million in the quarter ended June 30, 2008 as compared to $17.5 million in the quarter ended June 30, 2007. The increase in operating expenses was primarily attributable to the expensing of in-process research and development arising from the acquisition of assets from ACI, an increase in sales and marketing costs as a result of the expansion of the Company's sales forces in the United States and Europe in early fiscal 2008, expansion of the Company's clinical education programs, and additional higher employee-related expenses.

Net loss per share applicable to common stockholders decreased to $0.43 for the quarter ended June 30, 2008 as compared to $1.20 for the quarter ended June 30, 2007, due primarily to the increase in the shares outstanding as a result of the sale of 11.5 million shares of common stock in the Company's November 2007 initial public offering and the conversion of 30.4 million shares of preferred stock into common stock concurrent with this public offering.

Fiscal Year 2009 Guidance:

BioForm Medical is providing the following financial guidance for the full fiscal year ended June 30, 2009:

-- Revenues are expected to be approximately $74 to $78 million.

-- Gross profit is expected to average approximately 81% to 83% as a

percentage of sales on an annual basis, with some possible fluctuation

outside of this range on a quarterly basis.

-- Operating expenses are expected to be approximately $84 to $86 million.

-- Net loss is expected to be approximately $20 to $23 million.

Product Pipeline Update:

BioForm Medical is providing the following update on its product pipeline:

-- RADIESSE(R) Dermal Filler Next-Generation Products: The Company has a


'/>"/>
SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioForm Medical to Present at the 2008 JPMorgan Healthcare Conference on January 7, 2008
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... light, developed by researchers at the University of Cambridge, ... the realm of science fiction, such as invisibility cloaks ... be a reality for quite some time, the technique ... blocks a few billionths of a metre across can ... through them, and works on large chunks all at ...
(Date:7/28/2014)... 2014 According to a new ... "Regenerative Medicine (Bone and Joint) Market (By Technology ... By Applications - Bone Graft Substitutes, Osteoarticular Diseases, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, ... and joint) market was valued at USD 2.6 ...
(Date:7/28/2014)... According to the ... Instruments, Services), Methods (Phenotypic, Genotypic), Applications (Pharmaceutical, Diagnostic, Environmental, ... - Global Forecasts to 2019" published by ... at $896.5 Million in 2014 and is ... growing at a CAGR of 5.9% from ...
(Date:7/28/2014)... Louis, MO (PRWEB) July 28, 2014 ... software, and services that bring the power of genomics ... the inaugural Appistry Pipeline Challenge . , ... Bell, president of the National Center for Genome Resources, ... Mercy Hospitals and Clinics of Kansas City. Rounding out ...
Breaking Biology Technology:Building 'invisible' materials with light 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition 2
... Animal Fats, Uses No Water, Produces Pure Glycerin, ... Benefuel, Inc., a,new-generation biodiesel refining and distribution company, ... industrial-scale biodiesel refinery,leveraging a novel solid catalyst that ... plant, planned to be located in Seymour,Ind., eliminates ...
... team of Cornell nanotechnology researchers has unraveled some ... holds promise for light-emitting, flexible semiconductors., The discovery, ... building a specific type of light-emitting device, is ... the journal Nature Materials ., The interdisciplinary ...
... VSGN ; TSX:VAS), today reported the results of operations ... herein are in Canadian,dollars unless otherwise noted. At ... restricted cash,totaled $29.1 million, compared with $33.8 million at ... during the second quarter, we no,longer have any restricted ...
Cached Biology Technology:New Benefuel Refinery Targets Key Flaws in Biodiesel Production 2New Benefuel Refinery Targets Key Flaws in Biodiesel Production 3CU researchers shed light on light-emitting nanodevice 2Vasogen Announces Third Quarter 2007 Results 2Vasogen Announces Third Quarter 2007 Results 3Vasogen Announces Third Quarter 2007 Results 4Vasogen Announces Third Quarter 2007 Results 5Vasogen Announces Third Quarter 2007 Results 6Vasogen Announces Third Quarter 2007 Results 7Vasogen Announces Third Quarter 2007 Results 8Vasogen Announces Third Quarter 2007 Results 9Vasogen Announces Third Quarter 2007 Results 10Vasogen Announces Third Quarter 2007 Results 11Vasogen Announces Third Quarter 2007 Results 12Vasogen Announces Third Quarter 2007 Results 13
(Date:7/28/2014)... the United States have a circulatory problem of the ... and may even require surgery in serious cases. This ... in turn, limb amputation. , At The University of ... scientists tested a non-surgical preventative treatment in a mouse ... increased blood circulation. Their proof-of-concept study appears in ...
(Date:7/28/2014)... have pinpointed a mechanism in part of the brain that ... it to both type 1 and type 2 diabetes. The ... Proceedings of the National Academies of Sciences . , ... a part of the hypothalamus known as the ventromedial nucleus ... glucose levels in the blood," said lead author Sabrina Diano, ...
(Date:7/28/2014)... 10 U.S. cities that have seen an increase in ... road closures, overwhelmed storm drains and compromised infrastructure--are on ... report. , This nuisance flooding, caused by rising sea ... 300 and 925 percent since the 1960s. , The ... around the United States, also finds Annapolis and Baltimore, ...
Breaking Biology News(10 mins):Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2Glucose 'control switch' in the brain key to both types of diabetes 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3
... by researchers at Baylor College of Medicine (BCM) and ... DNA sequencing to the patient's bedside, the doctor's office ... battlefield. , "We could eventually do direct detection of ... performed in the laboratory, said Dr. Michael L. Metzker, ...
... to block cat allergies successfully prevented allergic reactions in ... a test tube, University of California, Los Angeles (UCLA) ... available online now. In the future, the investigators say, ... not only for human cat allergies, but also possibly ...
... of a molecular machine that can cut and paste ... diseases such as some forms of cancer and opportunistic ... froze one of these molecular machines, which are chemical ... in its work cycle. When frozen, crystallized introns reveal ...
Cached Biology News:Color-blind method opens new doors in DNA sequencing 2Color-blind method opens new doors in DNA sequencing 3Novel Therapy Tested in Mice Could Chase Away Cat Allergies 2Novel Therapy Tested in Mice Could Chase Away Cat Allergies 3Molecular machine may lead to new drugs to combat human diseases 2Molecular machine may lead to new drugs to combat human diseases 3
... Blunt TOPO PCR Cloning Kit offers ... high-efficiency (>=95%) cloning of blunt-end PCR ... The kit includes the linearized and ... 5-minute bench-top ligations without ligase (1). ...
2.0 GHz Compaq Computer with 512 MB RAM, 32 MB AGP Graphics Card, 40 GB Hard Drive, 1 Serial Port & Open PCI Slot, Windows 2000 OS, MS Office, CD Read/Writer and 18 Flat Panel Monitor...
Blot Paper 7 x 8.5cm semi-dry western blots (order number RB-400)...
... Normal;heading 1;heading 2;Many ... and experimental situations ... standard transfection and ... systems. ViraPower Lentiviral ...
Biology Products: